Literature DB >> 12219108

Morbidity and survival in advanced AIDS in Rio de Janeiro, Brazil.

Angela J Gadelha1, Náurea Accacio, Regina L B Costa, Maria Clara Galhardo, Maria Regina Cotrim, Rogério V de Souza, Mariza Morgado, Keyla Marzochi, Maria Cristina Lourenco, Valeria C Rolla.   

Abstract

Opportunistic diseases (OD) are the most common cause of death in AIDS patients. To access the incidence of OD and survival in advanced immunodeficiency, we included 79 patients with AIDS treated at Hospital Evandro Chagas (FIOCRUZ) from September 1997 to December 1999 with at least one CD4 count <or=100 cells/mm(3). The incidence of OD was analyzed by Poisson's regression, and survival by Kaplan Meier and Cox analysis, considering a retrospective (before CD4 <or=100 cells/mm(3)) and a prospective (after CD4 <or=100 cells/mm(3)) period, and controlling for demographic, clinical and laboratory characteristics. The confidence interval estipulated was 95%. Mean follow-up period was 733 days (CI = 683-782). During the study 9 (11.4%) patients died. Survival from AIDS diagnosis was a mean of 2589 days (CI = 2363-2816) and from the date of the CD4 count CD4 <or=100 cells/mm(3) was a mean of 1376 (CI = 1181-1572) days. Incidence of OD was 0.51 pp/y before CD4 <or= 100 cells/mm(3) and 0.29 pp/y after CD4 <or= 100 cells/mm(3). A lower number of ODs before CD4 < 100 cells/mm(3) was associated with lower incidence rates after CD4 <or= 100 cells/mm(3). AIDS diagnosis based on CD4+ counts <or= 200 cells/mm(3) was associated with lower incidence rates after CD4 <or= 100 cells/mm(3). Baseline CD4 counts above 50 cells/mm(3) (HR = 0.13) and restoration of baseline CD4+ counts above 100 cells/mm(3) (HR = 0.16) were associated with a lower risk of death. Controlling both variables, only restoration of baseline counts was statistically significant (HR = 0.22, p = 0.04). We found a very low incidence of OD and long survival after CD4 < 100 cells/mm(3). Survival was significantly associated with restoration of baseline CD4 counts above 100 cells/mm(3).

Entities:  

Mesh:

Year:  2002        PMID: 12219108     DOI: 10.1590/s0036-46652002000400001

Source DB:  PubMed          Journal:  Rev Inst Med Trop Sao Paulo        ISSN: 0036-4665            Impact factor:   1.846


  7 in total

1.  Safety, efficacy and pharmacokinetics of ritonavir 400mg/saquinavir 400mg twice daily plus rifampicin combined therapy in HIV patients with tuberculosis.

Authors:  Valeria Cavalcanti Rolla; Maria A da Silva Vieira; Douglas Pereira Pinto; Maria C Lourenço; Carlos da Silva de Jesus; Mariza Gonçalves Morgado; Milton Ferreira Filho; Eduardo Werneck-Barroso
Journal:  Clin Drug Investig       Date:  2006       Impact factor: 2.859

2.  Assessment of the impact of adherence and other predictors during HAART on various CD4 cell responses in resource-limited settings.

Authors:  Danho Pascal Abrogoua; Brou Jerome Kablan; Boua Alexis Thierry Kamenan; Gilles Aulagner; Konan N'guessan; Christian Zohoré
Journal:  Patient Prefer Adherence       Date:  2012-03-23       Impact factor: 2.711

3.  Prevalence of Opportunistic Infections and Associated Factors in HIV-Infected Men Who Have Sex With Men on Antiretroviral Therapy in Bach Mai Hospital, Hanoi, Vietnam: A Case-Control Study.

Authors:  Linh Vu Phuong Dang; Quan Hai Nguyen; Azumi Ishizaki; Mattias Larsson; Nhung Thi Phuong Vu; Cuong Do Duy; Linus Olson; Thanh Thi Dinh
Journal:  Am J Mens Health       Date:  2020 May-Jun

4.  Assessing different perspectives on the value of a pharmaceutical innovation.

Authors:  Albert Wertheimer; Larry Radican; Michael Robert Jacobs
Journal:  South Med Rev       Date:  2010-02-15

Review 5.  Antiretroviral therapy in children: recent advances.

Authors:  Rakesh Lodha; Mamta Manglani
Journal:  Indian J Pediatr       Date:  2012-11-27       Impact factor: 5.319

Review 6.  Disparities in the Magnitude of Human Immunodeficiency Virus-related Opportunistic Infections Between High and Low/Middle-income Countries: Is Highly Active Antiretroviral Therapy Changing the Trend?

Authors:  M O Iroezindu
Journal:  Ann Med Health Sci Res       Date:  2016 Jan-Feb

Review 7.  Trends in overall opportunistic illnesses, Pneumocystis carinii pneumonia, cerebral toxoplasmosis and Mycobacterium avium complex incidence rates over the 30 years of the HIV epidemic: a systematic review.

Authors:  Lara Coelho; Valdiléa Gonçalves Veloso; Beatriz Grinsztejn; Paula Mendes Luz
Journal:  Braz J Infect Dis       Date:  2013-11-23       Impact factor: 3.257

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.